Anzeige
Mehr »
Donnerstag, 13.11.2025 - Börsentäglich über 12.000 News
BREAKING NEWS: Bohrprogramm gestartet - historisches Uranpotenzial wird jetzt "aufgebohrt"
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
23.10.Secarna Pharmaceuticals, Scenic Biotech Enter Drug Discovery & Co-Development Pact
23.10.BioMed X and Daiichi Sankyo Launch Immuno-Oncology Research Team
22.10.ProImmune Opens New Global Headquarters in Oxford
22.10.Sharp Services Invests $100M in U.S. and European Facilities
22.10.Takeda Licenses Late-Stage Cancer Drugs from Innovent in $1.2 Billion Deal
22.10.Cambrex Invests $120M to Expand U.S. API Manufacturing Ops
22.10.Basking Biosciences Names Dr. Julia Owens as CEO
22.10.Charles River, Francis Crick Institute Develop Antibody-Drug Conjugate
22.10.Alkermes to Acquire Avadel Pharmaceuticals for $2.1 Billion
21.10.Ajinomoto Bio-Pharma, Gene Tools Partner to Broaden Access to PMOs
21.10.Adare Expands Pessano Facility in Milan
21.10.Newleos Therapeutics Appoints Timothy Noyes as President & CEO
21.10.Ventus Therapeutics & Genentech Enter Collaboration
21.10.Galapagos Considers Winding Down Cell Therapy Business
20.10.Ashland Expands Portfolio of High Purity Sugar Excipients
20.10.Mosaic Therapeutics Taps Thomas Fuchs as CEO
20.10.Orsini Launches Integrated Specialty Pharmacy & 3PL Solution
20.10.ABT Expands Global Presence and Agarose Resins Capabilities
20.10.ACG to Invest $200M in U.S. Empty-Capsule Manufacturing Operations
20.10.Charles River, X-Chem Enter Strategic Collaboration
20.10.Merck Begins Construction of $3B Pharmaceutical Manufacturing Facility in VA
17.10.Savara Promotes Dr. Yasmine Wasfi to Chief Medical Officer
16.10.Cytek Biosciences Expands with New Facility in Amsterdam
16.10.EVOQ Therapeutics and Sanofi Enter Collaboration and License Agreement
16.10.Immunai to Advance Inflammatory Bowel Disease Target with AstraZeneca